NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zealand Pharma A/S (PINK: ZLDPF)

 
ZLDPF Technical Analysis
1.5
As on 12th Dec 2025 ZLDPF SHARE Price closed @ 78.73 and we RECOMMEND Buy for LONG-TERM with Stoploss of 52.53 & Sell for SHORT-TERM with Stoploss of 87.52 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ZLDPFSHARE Price

Open 78.00 Change Price %
High 78.73 1 Day -1.13 -1.41
Low 78.00 1 Week -4.32 -5.20
Close 78.73 1 Month -1.02 -1.28
Volume 218 1 Year -21.36 -21.34
52 Week High 110.00 | 52 Week Low 50.14
 
PINK USA Most Active Stocks
CBGL 0.00 %
TXGE 3316.21 2.69%
VIVK 0.07 0.00%
BFCH 0.00 %
UMAV 0.00 %
TMSH 0.00 %
APLD 27.86 -9.43%
XTRM 0.00 %
WHEN 0.00 %
CRWG 3.73 -20.30%
 
PINK USA Top Gainers Stocks
ANAV 12.05 30025.00%
BSSMF 1.00 9900.00%
CGGYY 41.88 6765.57%
BKGM 950.00 6566.67%
BCWG 1.44 4700.00%
GPGC 0.40 3900.00%
IHRTB 2.49 2390.00%
URCFF 0.20 900.00%
EVGUF 0.19 850.00%
GARLF 1.22 838.46%
 
PINK USA Top Losers Stocks
UCIX 0.00 -100.00%
SKLV 0.06 -100.00%
SKLV 0.06 -100.00%
RCCMF 0.02 -100.00%
RCCMF 0.02 -100.00%
MSET 0.00 -100.00%
MSET 0.00 -100.00%
GMETF 0.27 -100.00%
GMETF 0.27 -100.00%
STSN 0.00 -100.00%
 
 
ZLDPF
Daily Charts
ZLDPF
Intraday Charts
Whats New @
Bazaartrend
ZLDPF
Free Analysis
 
ZLDPF Important Levels Intraday
RESISTANCE80.14
RESISTANCE79.69
RESISTANCE79.41
RESISTANCE79.13
SUPPORT78.33
SUPPORT78.05
SUPPORT77.77
SUPPORT77.32
 
ZLDPF Forecast December 2025
4th UP Forecast148.68
3rd UP Forecast126.25
2nd UP Forecast112.38
1st UP Forecast98.51
1st DOWN Forecast58.95
2nd DOWN Forecast45.08
3rd DOWN Forecast31.21
4th DOWN Forecast8.78
 
ZLDPF Weekly Forecast
4th UP Forecast97.52
3rd UP Forecast91.49
2nd UP Forecast87.77
1st UP Forecast84.04
1st DOWN Forecast73.42
2nd DOWN Forecast69.69
3rd DOWN Forecast65.97
4th DOWN Forecast59.94
 
ZLDPF Forecast2025
4th UP Forecast194.08
3rd UP Forecast157.09
2nd UP Forecast134.22
1st UP Forecast111.35
1st DOWN Forecast46.11
2nd DOWN Forecast23.24
3rd DOWN Forecast0.37
4th DOWN Forecast-36.62
 
 
ZLDPF Other Details
Segment EQ
Market Capital 1372448384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ZLDPF Address
ZLDPF
 
ZLDPF Latest News
 
Your Comments and Response on Zealand Pharma A/S
 
ZLDPF Business Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Address: Sydmarken 11, Copenhagen, Denmark, 2860
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service